Skip to main content
. 2019 Sep;21(5):873–883. doi: 10.1016/j.jmoldx.2019.05.006

Figure 5.

Figure 5

Schematic diagram of protein domains of selected fusions, detailed fusion sequences, and Sanger confirmation. A: KIAA1549-BRAF and GIT2-BRAF in pilocytic astrocytoma patients. B: Two different BCR-ABL1 fusions in a chronic myeloid leukemia (CML) and a B-cell acute lymphoblastic leukemia (B-ALL) patient. C:CENPC-ABL1 in a B-ALL patient. Black arrows indicate the direction of reading frame; red arrows, the break points on mRNA level.